Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995 Jul 3;14(13):3116-26.
doi: 10.1002/j.1460-2075.1995.tb07314.x.

Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases

Affiliations
Comparative Study

Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases

R Brambilla et al. EMBO J. .

Abstract

The Eph-related family of receptor tyrosine kinases consists of at least 13 members, several of which display distinctive expression patterns in the developing and adult nervous system. Recently, a small family of ligands, structurally related to the B61 protein, was identified. Binding of these ligands to Eph-related receptors did not, however, elicit measurable biological signals in cultured cells. In order to study functional interactions between B61-related ligands and Eph-related receptors, we constructed chimeric receptors, containing an Eph-related ectodomain and the cytoplasmic domain of the TrkB neurotrophin receptor. Expression and activation of such chimeric receptors in NIH 3T3 cells induced transformation in focus formation assays. Membrane-bound LERK2 ligand is shown to signal through three different Eph-related receptors, namely Cek5, Cek10 and Elk. LERK2, however, fails to interact functionally with the Cek9 receptor. Quantitative analysis including binding assays indicates that Cek10 is the preferred LERK2 receptor. Preliminary mutagenesis of the LERK2 protein suggests a negative regulatory role for its cytoplasmic domain in LERK2 signaling.

PubMed Disclaimer

References

    1. J Virol. 1969 Nov;4(5):549-53 - PubMed
    1. Oncogene. 1993 Aug;8(8):2033-42 - PubMed
    1. EMBO J. 1993 Aug;12(8):3083-94 - PubMed
    1. Oncogene. 1993 Oct;8(10):2857-62 - PubMed
    1. Mol Cell Biol. 1993 Nov;13(11):7071-9 - PubMed

Publication types

MeSH terms